Main > ONCOLOGY (**) > Breast Cancer>MET>HER2->gBRCA->* > TREAT.: > Co: USA. P. Talazoparib

---

Co: USA. P. Talazoparib's subsections
(*) EU Approval Date: 2019. 06.21.
(*) USA Approval Date: 2018. 10.16.
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2018. 10.16.
TradeMark
TradeMark Web-Site

Co: USA. P. Talazoparib's products
This section has no products